SBI Symposium Collection Optimizing Your Practice

Experience top sessions from the 2025 SBI Breast Imaging Symposium—expert-led, high-yield, and designed to help radiologists close practice gaps and excel in clinical care.

SBI Symposium Collection: Optimizing Your Practice Lectures: 

1. Case Based Challenges: Raise your CDR and Lower your RR

Speaker:  

• Heather Greenwood, MD, FSBI 
• Catherine Giess, MD, FSBI 

2. Volume Issues: Balancing Quantity, Quality and Safety

Speakers: 

• Donna Plecha, MD, FSBI 
• Stamatia V. Destounis, MD, FSBI 

3. Language Matters: Communicating Results

Speakers: 

• Caroline P. Daly, MD
• Katerina Dodelzon, MD, FSBI

4. BI-RADS Audit and Outcomes

Speakers: 

• Peter Eby, MD, FSBI

Learning Objectives:

• Identify interpretation strategies in screening mammography to increase cancer detection rate.
• Review strategies in screening interpretation and lesion analysis to reduce false positive recalls for asymmetries, masses, and calcifications.
• To understand possible ways to reduce the impact of higher patient volumes, longer work-days and radiologist shortage with additional support staff and functional technology.
• Apply the 6 elements of the SPIKES protocol to empathetically discuss radiology and pathology results with a focus on malignant pathology.
• Describe the forthcoming changes to the audit section of the BI-RADS atlas.
• Appropriately categorize histology into positive and negative results for the purposes of the audit.

CME Released: 08/11/2025   CME Expires:  08/10/2028 

Joint Accreditation Statement - In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Breast Imaging . Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number: 4008163

Physicians - Amedco LLC designates this material for a maximum of 3.00 AMA PRA Category 1 Credits^TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learner Notification:

Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion

Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles, and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Breast Imaging . Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Professions in scope for this activity are listed below.

Amedco Joint Accreditation Provider Number: 4008163

Physicians - Amedco LLC designates this material for a maximum of 3.00 AMA PRA Category 1 Credits^TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5) 

All individuals in a position to control the content of CE are listed below.